Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Support | Bullish | 0.00% | |
| Crossed Above 20 DMA | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.62% | |
| Bollinger Band Squeeze | Range Contraction | 0.62% | |
| Gapped Up | Strength | 0.62% | |
| Bollinger Band Squeeze | Range Contraction | 1.42% | |
| BB Squeeze Started | Range Contraction | 1.42% |
| Alert | Time |
|---|---|
| 10 DMA Support | 3 days ago |
| Rose Above Previous Day's High | 3 days ago |
| 50 DMA Resistance | 3 days ago |
| 2x Volume Pace | 5 days ago |
| 1.5x Volume Pace | 5 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 38.8 |
| 52 Week Low | 23.1558 |
| Average Volume | 14,725 |
| 200-Day Moving Average | 31.40 |
| 50-Day Moving Average | 33.47 |
| 20-Day Moving Average | 33.62 |
| 10-Day Moving Average | 33.20 |
| Average True Range | 0.63 |
| RSI (14) | 52.61 |
| ADX | 10.73 |
| +DI | 37.44 |
| -DI | 31.48 |
| Chandelier Exit (Long, 3 ATRs) | 33.05 |
| Chandelier Exit (Short, 3 ATRs) | 34.38 |
| Upper Bollinger Bands | 34.75 |
| Lower Bollinger Band | 32.49 |
| Percent B (%b) | 0.58 |
| BandWidth | 6.73 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.09 |
| MACD Histogram | 0.0146 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 34.47 | ||||
| Resistance 3 (R3) | 34.44 | 34.18 | 34.36 | ||
| Resistance 2 (R2) | 34.18 | 34.01 | 34.19 | 34.32 | |
| Resistance 1 (R1) | 33.98 | 33.90 | 34.08 | 34.02 | 34.28 |
| Pivot Point | 33.73 | 33.73 | 33.78 | 33.74 | 33.73 |
| Support 1 (S1) | 33.53 | 33.56 | 33.63 | 33.57 | 33.30 |
| Support 2 (S2) | 33.28 | 33.45 | 33.29 | 33.27 | |
| Support 3 (S3) | 33.08 | 33.28 | 33.23 | ||
| Support 4 (S4) | 33.11 |
